SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-246896"
 

Search: onr:"swepub:oai:DiVA.org:uu-246896" > Effect of body mass...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

Aplenc, Richard (author)
Zhang, Mei-Jie (author)
Sung, Lillian (author)
show more...
Zhu, Xiaochun (author)
Ho, Vincent T (author)
Cooke, Kenneth (author)
Dvorak, Christopher (author)
Hale, Gregory (author)
Isola, Luis M (author)
Lazarus, Hillard M (author)
McCarthy, Philip L (author)
Olsson, Richard (author)
Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)
Pulsipher, Michael (author)
Pasquini, Marcelo C (author)
Bunin, Nancy (author)
show less...
 (creator_code:org_t)
American Society of Hematology, 2014
2014
English.
In: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 123:22, s. 3504-11
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The rising incidence of pediatric obesity may significantly affect bone marrow transplantation (BMT) outcomes. We analyzed outcomes in 3687 children worldwide who received cyclophosphamide-based BMT regimens for leukemias between 1990 and 2007. Recipients were classified according to age-adjusted body mass index (BMI) percentiles as underweight (UW), at risk of UW (RUW), normal, overweight (OW), or obese (OB). Median age and race were similar in all groups. Sixty-one percent of OB children were from the United States/Canada. Three-year relapse-free and overall survival ranged from 48% to 52% (P = .54) and 55% to 58% (P = .81) across BMI groups. Three-year leukemia relapses were 33%, 33%, 29%, 25%, and 21% in the UW, RUW, normal, OW, and OB groups, respectively (P < .001). Corresponding cumulative incidences for transplant-related mortality (TRM) were 18%, 19%, 21%, 22%, and 28% (P < .01). Multivariate analysis demonstrated a decreased risk of relapse compared with normal BMI (relative risk [RR] = 0.73; P < .01) and a trend toward higher TRM (RR = 1.28; P = .014). BMI in children is not significantly associated with different survival after BMT for hematologic malignancies. Obese children experience less relapse posttransplant compared with children with normal BMI; however, this benefit is offset by excess in TRM.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Blood (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view